ChoroPharma's Innovative Growth

ChoroPharma, LLC is a new company that will provide high quality generic ophthalmic medication to its patients. ChoroPharma is on track to begin operations soon. Troy Chavis, the founder of ChoroPharma, has obtained degrees in both Chemical Engineering and Biology, and has spent years in small molecule pharmaceutical generic manufacturing with specialization in aseptically filled products. ChoroPharma strives to deliver quality pharmaceutical products at a generic cost.

The market for generic ophthalmic suspensions is a billion dollar market in the U.S. and worldwide. ChoroPharma has recognized the high demand for these products, as well as a shortage in supply. With this strategy, we have the potential to set the stage as an influential niche company for generic ophthalmic suspensions.